Community Shares | January 20th 2024
- A study published in The Lancet Psychiatry demonstrates the significant global prevalence and nonfatal health strain of ASD, emphasizing its widespread impact.
- New Danish research has found that glucocorticoid steroids, commonly prescribed to pregnant women to prevent premature births and treat conditions like asthma and rheumatoid arthritis, may increase their children’s risk of developing autism by up to 50%.
- A recent study has highlighted the need for primary care providers to adopt tailored approaches when treating individuals with autism who have co-occurring psychiatric and behavioral conditions.
- Recent research provides the first comprehensive comparison of creativity in individuals with autism and those without, accounting for general cognitive ability and ADHD.
Childhood Lead Exposure Linked to Worsening U.S. Mental Health Over 75 Years
A study published in the Journal of Child Psychology and Psychiatry suggests that childhood exposure to lead from vehicle exhaust may have significantly worsened mental health in the U.S. over the past 75 years, potentially contributing to 151 million excess psychiatric disorders.
Review Connects Lead Exposure to the Development of ADHD
The Journal of Neurodevelopmental Disorders has recently published a systematic review of 74 studies conducted between 1983 and 2023, exploring the link between Attention-Deficit/Hyperactivity Disorder (ADHD) and exposure to lead and exposure to mercury.
Children with Cerebral Palsy Face a Fivefold Increased Risk of ASD and a Double Risk of ADHD
A recent nationwide study has revealed a significant link between cerebral palsy and an increased risk of autism spectrum disorder (ASD) and attention/deficit-hyperactivity disorder (ADHD) in children.
SafeMinds Research for Autism Health
A study in Environmental Health Perspectives by Emily C. Somers and colleagues found that women of childbearing age with higher mercury levels in hair or blood were at much higher risk of developing antinuclear antibodies, a marker of autoimmunity.
